3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rhabdomyosarcoma
5
Wilms Tumor
4
Sarcoma
4
Hydatidiform Mole
2
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Fibrosarcoma
1
Choroid Plexus Neoplasms
1
Choriocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Blast Crisis
1
Beckwith-Wiedemann Syndrome
1
Interventions
pralsetinib
2
pembrolizumab
2
Brentuximab Vedotin
2
Bevacizumab
2
ribociclib
1
fosaprepitant
1
Sunitinib
1
Sirolimus
1
Radiotherapy, Image-Guided
1
Plicamycin
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Genistein
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dexamethasone
1
Cisplatin
1
Carboplatin
1
Aprepitant
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Germ Cell and Embryonal
×
Dactinomycin
×
Clear all
No trials found.